ADVISORY, Feb. 02, 2016 --
What:
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, David Stack, Chief Executive Officer and Chairman, will ring the Opening Bell.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When:
Wednesday, February 3, 2016 – 9:15 a.m. to 9:30 a.m. ET
Pacira Pharmaceuticals Media Contact:
Amber Sears
(973) 254-3587
[email protected]
Nasdaq MarketSite:
Emily Pan
(646) 441-5120
[email protected]
Feed Information:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK
Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
http://www.facebook.com/NASDAQ.
For photos from ceremonies and events visit our Instagram Page:
http://instagram.com/nasdaq
For news tweets, please visit our Twitter page at:
http://twitter.com/nasdaq
For exciting viral content and ceremony photos visit our Tumblr Page:
http://nasdaq.tumblr.com/
Webcast:
A LiveStream of the Nasdaq Opening Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos:
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About Pacira
Pacira Pharmaceuticals, Inc. (Nasdaq:PCRX) is a specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company’s flagship product, EXPAREL® (bupivacaine liposome injectable suspension), indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia, was commercially launched in the United States in April 2012. EXPAREL and two other products have successfully utilized DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. Additional information about Pacira is available at www.pacira.com.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.6 trillion and nearly 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
-NDAQA-


Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Google Secures Pentagon AI Deal for Classified Projects
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 



